Skip to main content
Signal8
Launch Terminal
WALLER GREGORY D profile photo

Gregory D. Waller

CIK: 0001204144

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Arcadia Biosciences, Inc. logo
RKDA

Arcadia Biosciences, Inc.

Director
Nuwellis, Inc. logo
NUWE

Nuwellis, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Arcadia Biosciences, Inc. logo
    RKDA

    Arcadia Biosciences, Inc.

    Sep 10, 2026
    Award(A)

    Stock Option (Right to Buy)

    Direct
    10K shares-
  • Nuwellis, Inc. logo
    NUWE

    Nuwellis, Inc.

    Apr 28, 2026
    Award(A)

    Nonstatutory Stock Option (right to buy)

    Direct
    6.7K shares-
  • Nuwellis, Inc. logo
    NUWE

    Nuwellis, Inc.

    May 20, 2025
    Award(A)

    Nonstatutory Stock Option (right to buy)

    Direct
    17.5K shares-

1-3 of 3

About WALLER GREGORY D

WALLER GREGORY D (SEC CIK 0001204144) files insider reports with the SEC as Director of Arcadia Biosciences, Inc. (RKDA) and Director of Nuwellis, Inc. (NUWE).

Signal8 holds 3 ownership filings by WALLER GREGORY D, all Form 4s, filed between May 21, 2025 and Sep 14, 2026. Those filings report 3 transactions, from May 20, 2025 to Sep 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on WALLER GREGORY D's filings is in DALLAS, TX.

Recent filings by WALLER GREGORY D

  • Sep 10, 2026: Grant or award of RKDA derivative securities (Form 4, code A).
  • Apr 28, 2026: Grant or award of NUWE derivative securities (Form 4, code A).
  • May 20, 2025: Grant or award of NUWE derivative securities (Form 4, code A).

Other insiders filing for Arcadia Biosciences, Inc. (RKDA)

How to read Form 4 transaction codes